WHO global research priorities for antimicrobial resistance in human health
WHO global research priorities for antimicrobial resistance in human health
By: Silvia Bertagnolio, Zlatina Dobreva, Chad M Centner, Ioana Diana Olaru, Daniele Donà, Stefano Burzo, Benedikt D Huttner, Antoine Chaillon, Nebiat Gebreselassie, Teodora Wi, Mateusz Hasso-Agopsowicz, Benedetta Allegranzi, Hatim Sati, Verica Ivanovska, Kavita U Kothari, Hanan H Balkhy, Alessandro Cassini, Raph L Hamers, Kitty Van Weezenbeek, on behalf of the WHO Research Agenda for AMR in Human Health Collaborators (Mohan P. Joshi)
Publication: The Lancet; 12 August 2024. DOI: 10.1016/S2666-5247(24)00134-4
Although there has been growing attention on antimicrobial resistance (AMR) research, significant knowledge gaps continue to hinder an effective response, especially in low- and middle-income countries (LMICs) that bear the highest burden of bacterial AMR. The World Health Organization (WHO) has set out 40 research priorities in its AMR agenda to be addressed by 2030, aiming to stimulate research and investment in generating evidence that deepens understanding of AMR dynamics and supports policy translation to reduce its impact. The authors, including MSH’s Mohan P. Joshi, present the first comprehensive effort to prioritize research on infections caused by drug-resistant bacteria and fungi, using a rigorous and validated methodology.